Acadia Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for Nuplazid (pimavanserin) 07/04/2018 Medications, SAN DIEGO--(BUSINESS WIRE)--Jun. 29, 2018-- Acadia Pharmaceuticals Inc. today announced FDA approval of a new...
Novel property of a new anti-tuberculosis drug 07/04/2018 Health News, University of Otago researchers have discovered a novel property of a new anti-tuberculosis drug which...